[ad_1]
The newspaper "The New York Times"A report in which she spoke about the progress made by scientists in their research on AIDS and prevention and their efforts to improve the quality of drugs in circulation to reduce the spread of the disease.
The newspaper said, in its report, translated by "Arab"The second victim, who seems to have started recovering from the AIDS virus, called the" London Patient ", has garnered a lot of attention in the media and made the headlines, as well as this week's research in the" Conference on Retroactive Viruses and Opportunistic Infections. "Scientists are making slow but steady progress in the measures and drugs needed to fight the epidemic, particularly in Africa.
According to a study, researchers found that injections of "Disquie", a modified combination of the drug "Trovada", were effective in controlling the virus with the least possible side effects. In addition, one of the largest AIDS prevention studies focusing on the one million test and treatment strategy in South Africa and Zambia yielded different results. Despite the effectiveness of home testing and the provision of treatment for advanced cases to reduce the number of new infections, the provision of timely treatment to all has not given the desired results.
Evidence of the effectiveness of AIDS injections is of great importance because many patients forget to take their medications every day or can not keep them at home, the newspaper said. The success of my study on injection drugs, Atlas and Flair, has given rise to the hope of experts to protect uninfected people. Doctors working in poor countries are eager to use these injections, but their distribution is a little more difficult than distributing the pills.
African women prefer this type of treatment because they do not want their husband or their family to discover that they are taking the drug and that they are wrongly supposed to have AIDS. Both studies tested a monthly regimen of hoodigraver and relépiferrerrine buttocks, where research found that 98% of patients preferred cereal injections. Capotigraver is also the best solution for poor countries because it does not require cooling.
Read more: The first experiment reveals promising results for HIV / AIDS
Clinical trials involving Discovery, the new modified Trovada formulation developed by the Gildad Science Foundation, have helped control the virus, as has Trovada, which helps protect patients by about 100%. HIV infection, whether through unprotected sex or injection drug use.
The newspaper announced that the "Gilead" would seek approval from the US Food and Drug Administration to begin marketing the drug "Discovery" as a preventative drug. However, some AIDS activists have worried about the adoption of this drug, while inexpensive versions of Trovada are available.
Experiments in 21 districts of Zambia and South Africa, known to have the highest rates of HIV infection in the world, aim to determine whether infection rates can be significantly reduced if team of consultants manages to convince most people to test the pills, In addition to tips, condoms, circumcision and other measures to reduce the number of injuries during the experiment, known as the BobArt name and adopted from 2013 to 2018.
AIDS rates were expected to decrease in communities where patients were receiving prompt treatment, but this was not the case, although tests indicate that more people continued to eat their medications. The investigators said that a more in-depth analysis would be carried out.
Overall, trials of people who received the pills immediately and those who took them only after the first signs of the disease showed that these strategies reduced the new infection rates by 20%.
The Dolphin-2 trial showed that 74% of women taking dutolagrafir during their third week of pregnancy did not have HIV in their blood at birth. Dr. Sai Ko, an HIV specialist at the University of Liverpool, said there was a "very important" difference in how quickly each drug would get rid of the virus. This is important because many African women are infected with advanced-stage AIDS, making it difficult to prevent transmission of the infection to their children.
Some children died from each test group, while a few were infected with the virus, the paper said. The researchers believe that the causes of death are not related to the drug, but to other causes such as sepsis or pneumonia. HIV infection occurred early in pregnancy before the drug could do its job.
[ad_2]
Source link
